OxyContin maker Purdue Pharma may settle legal claims with a new 'public trust' that would still be dedicated to profit

The government has tried to harness profit-driven drugmaking to serve public health before. The results were underwhelming.

David Herzberg, Associate Professor of History, University at Buffalo • conversation
Oct. 21, 2020 ~10 min

history opioids philanthropy-and-nonprofits opioid-crisis oxycodone business-ethics oxycontin corporate-culture sackler-family purdue-pharma opioid-litigation

How gene editing a person's brain cells could be used to curb the opioid epidemic

A person dies of opioid overdose once every 13 minutes in the US. A researcher proposes a way using existing technology to remove the opioid target in people to prevent overdoses.

Craig W. Stevens, Professor of Pharmacology, Oklahoma State University • conversation
Aug. 5, 2020 ~9 min

 crispr  opioid  gene-editing  morphine  crisprcas  endorphins  analgesic  oxycodone